Aida Adlimoghaddam

513 citations
12 papers · 357 indexed · h-index 9
Topics
Alzheimer's disease research and treatments (7 papers)Neuroinflammation and Neurodegeneration Mechanisms (4 papers)Mitochondrial Function and Pathology (3 papers)

In The Last Decade

Aida Adlimoghaddam

12 papers receiving 354 citations

Peers

Aida Adlimoghaddam
Comparison fields: 5 of 85
  • Molecular Biology 148
  • Physiology 123
  • Neurology 52
  • Epidemiology 49
  • Biological Psychiatry 43
Replace Marlena Zyśk with:
Marlena Zyśk Poland
Christoph P. Stahlmann Germany
Carlos Sánchez-Garibay Mexico
Adriana Alarcón‐Aguilar Mexico
Hui Quan South Korea
Laura Mateos Sweden
Lu-Xiu Yang China
Aida Adlimoghaddam relative to Marlena Zyśk Poland Marlena Zyśk's profile →
Citations per field
00.5×1.5×2.1×
Marlena Zyśk · 1×
Citations per year

Countries citing papers authored by Aida Adlimoghaddam

Since Specialization
Citations

This map shows the geographic impact of Aida Adlimoghaddam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aida Adlimoghaddam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aida Adlimoghaddam more than expected).

Fields of papers citing papers by Aida Adlimoghaddam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aida Adlimoghaddam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aida Adlimoghaddam. The network helps show where Aida Adlimoghaddam may publish in the future.

Co-authorship network of co-authors of Aida Adlimoghaddam

This figure shows the co-authorship network connecting the top 25 collaborators of Aida Adlimoghaddam. A scholar is included among the top collaborators of Aida Adlimoghaddam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aida Adlimoghaddam. Aida Adlimoghaddam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2 1
3 2
4 21
5 60
6 32
7 80
8 25
9 17
10 26
11 14
12 77

About Aida Adlimoghaddam

Aida Adlimoghaddam is a scholar working on Biological Psychiatry, Neurology and Behavioral Neuroscience, having authored 12 papers that have together received 357 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Biological Psychiatry (43 citations), Neurology (52 citations) and Physiology (123 citations). Aida Adlimoghaddam has collaborated with scholars based in Canada, United States and Poland. Frequent co-authors include Benedict C. Albensi, Don A. Davies, Mohammad Golam Sabbir, Gordon W. Glazner, Raymond Scott Turner, Nahid Rezvani Jalal, Ryan M. West, Tayyebeh Madrakian, Stevan Pecic and Mehdi Eshraghi. Their work appears in journals such as Pharmacology & Therapeutics, Nutrients and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026